To view this email as a web page, click here.
 
CLINICAL UPDATES
 
Renal mass biopsy safe, but when is it necessary?
“While the safety and feasibility of the renal mass biopsy procedure has been established, if or when to obtain the biopsy remains a topic for active discussion,” writes Badar M. Mian, MD.
Read his column
 
The expanding role of immunotherapy in urologic cancers
Spencer Hart, MD, and Gopal Gupta, MD, explore the current and potential future use of immunotherapy in prostate, kidney, and bladder cancer.
Learn more
 
SURVEY
 
How concerned are you about the cost of prostate cancer treatment for your patients?
MORE FROM UROLOGY TIMES
 
PSA adjustments are required in men taking 5-ARIs
Pembro plus axitinib is new standard in advanced RCC
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.